Table of Contents Author Guidelines Submit a Manuscript
Volume 1, Pages 633-635
Directions in Science

Breaking Immunological Tolerance through OX40 (CD134)

Division of Immunochemistry, La Jolla Institute for Allergy and Immunology, San Diego, Ca, USA

Copyright © 2001 Pratima Bansal-Pakala and Michael Croft.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Brian H. Ladle, R. Todd Reilly, Leisha A. Emens, Eric R. Lutz, Matthew E. Wolpoe, Susan E. Ivie, Holly M. Smith, Todd D. Armstrong, Satoshi Murata, Elizabeth M. Jaffee, and Peter S. Kim, “OX40 costimulation synergizes with GM-CSF whole-cell vaccination to overcome established CD8+ T cell tolerance to an endogenous tumor antigen,” Journal of Immunology, vol. 176, no. 2, pp. 974–983, 2006. View at Publisher · View at Google Scholar
  • Hiroshi Yokouchi, Koichi Yamazaki, Kenji Chamoto, Eiki Kikuchi, Naofumi Shinagawa, Satoshi Oizumi, Fumihiro Hommura, Takashi Nishimura, and Masaharu Nishimura, “Anti-OX40 monoclonal antibody therapy in combination with radiotherapy results in therapeutic antitumor immunity to murine lung cancer,” Cancer Science, vol. 99, no. 2, pp. 361–367, 2008. View at Publisher · View at Google Scholar